Search Results 2011-2020 of 18762 for Relapse
Patients who have developed an asymptomatic relapse as defined by: Cohort A: CA-125 ≥ 2 times ULN on 2 occasions at least 1 week apart (GCIG criteria) or ...
Treatment of relapsed or refractory peripheral T cell lymphoma. https://www.uptodate.com/contents/search. Accessed Dec. 30, 2025. Elsevier Point of Care ...
Relapsed, progressing or persistent malignancy requiring withdrawal of systemic immune suppression. Patients with acute GVHD developing after a donor ...
who are definitively relapse-free with at least 3 years elapsed since the diagnosis of the other primary malignancy. Note: This criterion does not apply to ...
This is a Phase 1b/2 open-label study to evaluate the safety/efficacy of MEDI-551 + MEDI0680 (AMP-514) in participants with relapsed or refractory ...
Also, to improve disease control by decreasing the number of spinal relapses for patients who achieve a complete response (CR) or partial response (PR) and ...
Have histologically- or cytologically-confirmed disease, which is relapsed/ refractory, and unresectable or metastatic disease, following at least 1 prior ...
AI failures: Disease that relapsed during treatment or within 12 months of completion of adjuvant therapy with an AI, OR disease that progressed during ...
March 16, 2012. Dear Mayo Clinic: I was just diagnosed with relapsing polychondritis. What has been your experience with this disease? Answer:.
... relapsed, high-grade ovarian, fallopian tube, or primary peritoneal cancer. Participation eligibility. Participant eligibility includes age, gender, type and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.